retatrutide to tirzepatide Switching from retatrutide: the complete transition guide Retatrutide vs. Semaglutide vs. Tirzepatide:

It is also approved for blood sugar control in adults with type 2 diabetes

[1] [2] As of mid-2025, retatrutide has not received approval from the MHRA or EMA and remains under clinical investigation (ClinicalTrials

Is waist circumference changing

Furthermore, we summarize the current clinical applications of GLP-2 agonists among patients with intestinal failure associated with short bowel syndrome (SBS-IF) as well as potential future expansion of their indications to other intestinal disorders

Importantly, these trials exhibited a high degree of heterogeneity in terms of the types of substances studied, patient characteristics, and treatment protocols, which posed significant challenges to drawing definitive conclusions

Endpoints & analytics